Jae Yeong Park

Title: **Innovative Contributions of Jae Yeong Park in Antibody Technology**

Introduction

Jae Yeong Park, an inventor based in Gyeonggi-do, South Korea, has made significant strides in the field of antibody technology. With a total of two patents to his name, his work focuses on enhancing the capabilities of antibodies for targeted delivery in medical applications.

Latest Patents

Park's latest patents include groundbreaking advancements in cytosol-penetrating antibodies. One of his notable inventions is related to a cytosol-penetrating antibody that identifies a structural mechanism which facilitates escape from endosomes into the cytosol after cellular internalization. This discovery is based on the interaction with a cell membrane protein and significantly enhances the efficacy of antibodies in delivering therapeutic agents within living cells.

Another groundbreaking patent involves cell/tissue-specific cell-penetrating antibodies. This invention features cyclic peptides that can specifically bind to cell surface molecules, allowing for targeted delivery of therapeutic agents, such as polypeptides and antibodies. These cyclic peptide-containing antibodies demonstrate potential as effective anticancer agents, particularly for cancers overexpressing specific cell membrane proteins.

Career Highlights

Jae Yeong Park is currently associated with Orum Therapeutics Inc., a company that focuses on innovative therapeutic solutions leveraging advanced antibody technologies. His contributions are vital in the realm of targeted drug delivery and have enhanced the company's research initiatives.

Collaborations

Throughout his career, Park has collaborated with talented individuals, including colleagues Yong Sung Kim and Ji Sun Kim. These collaborations have furthered the development of his innovative ideas and reinforced the importance of teamwork in achieving significant scientific advancements.

Conclusion

Jae Yeong Park's inventive work in antibody technology exemplifies the impact of innovation on medicine. His patents represent a leap forward in developing therapeutics that are both effective and targeted, paving the way for future advancements in cancer treatment and beyond. As he continues to push the boundaries of research, Park remains a prominent figure in the field of biotechnology.